Elsevier Global Medical News/OncologyStat interviews Dr. Michael Gnant on the Austrian Breast and Colorectal Cancer Study Group-12 trial. The study assessed use of zoledronic acid...
FDA has issued an early communication to healthcare professionals about a possible association between bisphosphonate drugs, which are used to treat osteoporosis, and atrial fibrillation....
FDA is alerting healthcare professionals that severe bone, joint, or muscle pain can occur in patients taking bisphosphonate drugs such as Fosamax (alendronate sodium), Actonel...
Novartis has notified healthcare professionals about new warnings and dosing recommendations for the company's bisphosphonate drug, Zometa (zoledronic acid). Zometa is used to treat multiple...
http://www.medpagetoday.com Richard Eastell, M.D., University of Sheffield
MONTREAL, Sept. 15 -- The effect of zoledronic acid (Zometa) on osteoporotic fracture risks can be measured...
Vea la entrevista completa sólo en http://www.cedepap.tv
Erik F. Eriksen, M.D.
Ácido Zoledrónico: Evidencias del Programa HORIZON
- Especialidad: Osteología
Global Brand Medical Director de Aclasta/Reclast,...
